Dr. Kaveeta Vasisht is currently the acting Associate Commissioner and Deputy Director/Director of Research and Development in the Office of Women’s Health (OWH), in the Office of the Commissioner of the U.S. Food and Drug Administration (FDA). She began her career at the FDA in the Division of Metabolism and Endocrine Products, Office of New Drugs, Center for Drug Evaluation and Research (CDER), where she served as the clinical expert on multidisciplinary teams in the review and evaluation of scientific data to assess the safety, efficacy and approvability of drugs for the US market.
Subsequently, she joined CDER’s Office of Medical Policy where she most recently served as the Deputy Director of the Division of Clinical Trial Quality. Dr. Vasisht has extensive expertise in policy development across the drug development enterprise and has led multi-stakeholder collaborations nationally and internationally that are critical to the agency’s approach to improving clinical trial quality and methodologies; including the use of innovative technologies and real-world data. She has also worked to promote the inclusion of diverse populations in clinical trials by evaluating clinical trial eligibility criteria.
Dr Vasisht is double board-certified in both internal medicine and adult endocrinology and holds a Doctor of Pharmacy degree with high honors. She has completed her internal medicine internship and residency as well as fellowship training in adult endocrinology, diabetes and metabolism at the University of Chicago Hospitals, where she also served on the faculty. She obtained her medical degree from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. Dr. Vasisht continues to practice endocrinology part-time in a volunteer clinic. In her current role in the Office of Women’s Health, she combines her extensive academic and clinical training with her diverse regulatory background to further advance FDA’s mission to protect and advance the health of women.